Redeye states that Catella’s Q3 report was very strong – once again. While the company has postponed some divestments in Principal Investments, Redeye views this as proof of the company’s financial strength. This pushes half of the 2022 harvest into 2023. Investment Management once again delivered stellar results – and Redeye expects even better in Q4. Redeye raises its valuation.
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking.